We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Glatiramer Acetate (GA) in Patients With a First Episode of Acute Optic Neuritis

- Optic Neuritis
- Completed

Study Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)

Teva Identifier: PM030

ClinicalTrials.gov Identifier: NCT00856635

Study Status: Completed

Trial Condition(s): Optic Neuritis

Interventions: Drug: Glatiramer Acetate | Drug: placebo

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

inflammation and infections icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 45 Years

Trial Duration: 02/01/2009 - 02/01/2011

Phase: Phase 3

Study Type

Interventional